Cellular senescence in tumor immune escape: Mechanisms, implications, and therapeutic potential
Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collabora...
Saved in:
| Published in | Critical reviews in oncology/hematology Vol. 208; p. 104628 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.04.2025
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collaboration with immune cells and evading immune cell attacks by upregulating immunoinhibitory proteins. However, the intricate immune escape mechanism of cellular senescence in the tumor microenvironment remains a subject of intense investigation. Chronic inflammation is exacerbated by cellular senescence through the upregulation of pro-inflammatory factors such as interleukin-1β, thereby augmenting the risk of tumorigenesis. Additionally, the interplay between autophagy and cellular senescence adds another layer of complexity. Autophagy, known to slow down the aging process by reducing p53/p21 levels, may be downregulated by cellular senescence. To harness the therapeutic potential of cellular senescence, targeting its immunological aspects has gained significant attention. Strategies such as immune checkpoint inhibitors and T-cell senescence inhibition are being explored in the context of cellular senescence immunotherapy. In this comprehensive review, we provide a compelling overview of the regulation of cellular senescence and delve into the influencing factors, including chronic inflammation, autophagy, and circadian rhythms, associated with senescence in the tumor microenvironment. We specifically focus on unraveling the enigmatic dual role of cellular senescence in tumor immune escape. By deciphering the intricate nature of cellular senescence in the tumor microenvironment, this review aims to advance our understanding and pave the way for leveraging senescence as a promising target for tumor immunotherapy applications.
[Display omitted]
•Understanding the mechanism of cellular senescence and tumor immune escape leads to better tumor therapy.•Cellular senescence plays a dual role in tumor immune escape.•Chronic inflammation and autophagy, are linked to cellular senescence.•Circadian rhythms regulate cellular senescence, which is associated with tumor immune escape.•Targeting cellular senescence in immunotherapy is a promising approach in cancer treatment. |
|---|---|
| AbstractList | Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collaboration with immune cells and evading immune cell attacks by upregulating immunoinhibitory proteins. However, the intricate immune escape mechanism of cellular senescence in the tumor microenvironment remains a subject of intense investigation. Chronic inflammation is exacerbated by cellular senescence through the upregulation of pro-inflammatory factors such as interleukin-1β, thereby augmenting the risk of tumorigenesis. Additionally, the interplay between autophagy and cellular senescence adds another layer of complexity. Autophagy, known to slow down the aging process by reducing p53/p21 levels, may be downregulated by cellular senescence. To harness the therapeutic potential of cellular senescence, targeting its immunological aspects has gained significant attention. Strategies such as immune checkpoint inhibitors and T-cell senescence inhibition are being explored in the context of cellular senescence immunotherapy. In this comprehensive review, we provide a compelling overview of the regulation of cellular senescence and delve into the influencing factors, including chronic inflammation, autophagy, and circadian rhythms, associated with senescence in the tumor microenvironment. We specifically focus on unraveling the enigmatic dual role of cellular senescence in tumor immune escape. By deciphering the intricate nature of cellular senescence in the tumor microenvironment, this review aims to advance our understanding and pave the way for leveraging senescence as a promising target for tumor immunotherapy applications.
[Display omitted]
•Understanding the mechanism of cellular senescence and tumor immune escape leads to better tumor therapy.•Cellular senescence plays a dual role in tumor immune escape.•Chronic inflammation and autophagy, are linked to cellular senescence.•Circadian rhythms regulate cellular senescence, which is associated with tumor immune escape.•Targeting cellular senescence in immunotherapy is a promising approach in cancer treatment. Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collaboration with immune cells and evading immune cell attacks by upregulating immunoinhibitory proteins. However, the intricate immune escape mechanism of cellular senescence in the tumor microenvironment remains a subject of intense investigation. Chronic inflammation is exacerbated by cellular senescence through the upregulation of pro-inflammatory factors such as interleukin-1β, thereby augmenting the risk of tumorigenesis. Additionally, the interplay between autophagy and cellular senescence adds another layer of complexity. Autophagy, known to slow down the aging process by reducing p53/p21 levels, may be downregulated by cellular senescence. To harness the therapeutic potential of cellular senescence, targeting its immunological aspects has gained significant attention. Strategies such as immune checkpoint inhibitors and T-cell senescence inhibition are being explored in the context of cellular senescence immunotherapy. In this comprehensive review, we provide a compelling overview of the regulation of cellular senescence and delve into the influencing factors, including chronic inflammation, autophagy, and circadian rhythms, associated with senescence in the tumor microenvironment. We specifically focus on unraveling the enigmatic dual role of cellular senescence in tumor immune escape. By deciphering the intricate nature of cellular senescence in the tumor microenvironment, this review aims to advance our understanding and pave the way for leveraging senescence as a promising target for tumor immunotherapy applications. Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collaboration with immune cells and evading immune cell attacks by upregulating immunoinhibitory proteins. However, the intricate immune escape mechanism of cellular senescence in the tumor microenvironment remains a subject of intense investigation. Chronic inflammation is exacerbated by cellular senescence through the upregulation of pro-inflammatory factors such as interleukin-1β, thereby augmenting the risk of tumorigenesis. Additionally, the interplay between autophagy and cellular senescence adds another layer of complexity. Autophagy, known to slow down the aging process by reducing p53/p21 levels, may be downregulated by cellular senescence. To harness the therapeutic potential of cellular senescence, targeting its immunological aspects has gained significant attention. Strategies such as immune checkpoint inhibitors and T-cell senescence inhibition are being explored in the context of cellular senescence immunotherapy. In this comprehensive review, we provide a compelling overview of the regulation of cellular senescence and delve into the influencing factors, including chronic inflammation, autophagy, and circadian rhythms, associated with senescence in the tumor microenvironment. We specifically focus on unraveling the enigmatic dual role of cellular senescence in tumor immune escape. By deciphering the intricate nature of cellular senescence in the tumor microenvironment, this review aims to advance our understanding and pave the way for leveraging senescence as a promising target for tumor immunotherapy applications.Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention and treatment. In the tumor microenvironment, senescent cells exhibit a dual role, simultaneously hindering tumor development through collaboration with immune cells and evading immune cell attacks by upregulating immunoinhibitory proteins. However, the intricate immune escape mechanism of cellular senescence in the tumor microenvironment remains a subject of intense investigation. Chronic inflammation is exacerbated by cellular senescence through the upregulation of pro-inflammatory factors such as interleukin-1β, thereby augmenting the risk of tumorigenesis. Additionally, the interplay between autophagy and cellular senescence adds another layer of complexity. Autophagy, known to slow down the aging process by reducing p53/p21 levels, may be downregulated by cellular senescence. To harness the therapeutic potential of cellular senescence, targeting its immunological aspects has gained significant attention. Strategies such as immune checkpoint inhibitors and T-cell senescence inhibition are being explored in the context of cellular senescence immunotherapy. In this comprehensive review, we provide a compelling overview of the regulation of cellular senescence and delve into the influencing factors, including chronic inflammation, autophagy, and circadian rhythms, associated with senescence in the tumor microenvironment. We specifically focus on unraveling the enigmatic dual role of cellular senescence in tumor immune escape. By deciphering the intricate nature of cellular senescence in the tumor microenvironment, this review aims to advance our understanding and pave the way for leveraging senescence as a promising target for tumor immunotherapy applications. |
| ArticleNumber | 104628 |
| Author | You, Li Wu, Qinghua |
| Author_xml | – sequence: 1 givenname: Li surname: You fullname: You, Li organization: College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing 401520, China – sequence: 2 givenname: Qinghua surname: Wu fullname: Wu, Qinghua email: wqh212@hotmail.com organization: College of Life Science, Yangtze University, Jingzhou 434025, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39864532$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkEtPAyEUhYmpUVv9C4alC6cyA2WoK7XxlWjcdE8Y5hqpDIzANPHfS1Mfiauu4J577knON0Yj5x0ghEsyLUnJL1ZTHUwKsPZOTytSzbLMeCX20FEp6nmRh3KU_4SRQrBKHKJxjCtCCGO8PkCHdC44m9HqCMkFWDtYFXAEB1GD04CNw2nofMCm6wYHOOuqh0v8DPpNORO7eJ5XvTVaJeNdnpRrcXqDkG1DMhr3PoFLRtljtP-qbIST73eClne3y8VD8fRy_7i4fio0rXkqZm0rGkGaOeeMtkBqwQTkpkI1pJnVQKsKOCtZXuS6FaFzBgBCb_QaBJ2gs21sH_zHADHJzuQy1ioHfoiSlpwQLgSts_X02zo0HbSyD6ZT4VP-MMkGsTXo4GMM8PprKYnc4Jcr-YdfbvDLLf58erM9hVx1bSDIqM0GaWsC6CRbb3YJufoXoq1xmbV9h8_dIr4AVrWotw |
| Cites_doi | 10.1126/sciadv.aaz4530 10.1016/j.cell.2023.03.007 10.1038/ncb2784 10.1136/gutjnl-2016-312268 10.1146/annurev-physiol-030212-183653 10.1038/bjc.2017.336 10.7150/jca.61556 10.3389/fimmu.2021.636568 10.1186/s12967-023-04257-6 10.1073/pnas.2214829120 10.1038/s41573-018-0006-z 10.1038/s41586-022-05388-4 10.1038/cmi.2012.67 10.1038/s41577-022-00751-y 10.3390/biomedicines9050557 10.1016/j.cmet.2020.10.021 10.1038/s41418-019-0292-y 10.1101/gad.349585.122 10.1016/j.jcmgh.2022.04.003 10.1002/hep.31872 10.1038/s41594-022-00790-y 10.3390/cancers12113189 10.3390/ijms222413311 10.1093/bib/bbac118 10.1016/j.ccell.2016.09.003 10.1016/j.smim.2019.04.003 10.1186/s12943-022-01581-1 10.1136/annrheumdis-2021-221091 10.1038/ncb3225 10.1172/JCI153167 10.1007/s11154-022-09777-y 10.1016/j.immuni.2014.02.002 10.1016/j.trecan.2016.10.001 10.1158/0008-5472.CAN-12-2807 10.3390/cells9010195 10.1172/JCI95148 10.1158/2159-8290.CD-16-0062 10.1074/jbc.RA120.012962 10.1016/j.tcb.2022.04.011 10.1016/j.ymthe.2024.09.026 10.1038/s41392-022-00899-y 10.1080/2162402X.2022.2154115 10.1186/s13045-024-01581-2 10.1016/j.exger.2021.111394 10.1016/j.cell.2020.03.008 10.1038/s41467-021-27349-7 10.1038/ncomms7967 10.3389/fcell.2021.759761 10.1038/s41580-020-00314-w 10.1172/JCI158450 10.1056/NEJMoa1917346 10.1016/j.arr.2018.02.001 10.1158/2159-8290.CD-23-0426 10.1038/s41467-023-36124-9 10.1002/ctm2.1418 10.1158/2159-8290.CD-21-1059 10.1111/acel.13027 10.1186/s12943-021-01398-4 10.1038/s41418-018-0141-4 10.3390/v13122396 10.1016/j.cell.2018.09.048 10.1093/cvr/cvy206 10.3390/ijms22052238 10.1038/nrc3239 10.1038/s41467-022-32311-2 10.1158/2159-8290.CD-22-0528 10.1038/s41467-019-10335-5 10.1038/s41392-023-01502-8 10.1128/mcb.00171-22 10.1038/ncb3195 10.1136/jitc-2022-005020 10.3389/fcell.2021.645593 10.1186/s12890-022-02237-y 10.3389/fimmu.2021.698565 10.1016/j.isci.2020.102016 10.1161/ATVBAHA.115.305896 10.1182/blood.2020005244 10.1016/j.immuni.2019.03.024 10.1172/JCI90328 10.1007/s00280-021-04363-6 10.1158/0008-5472.CAN-07-2282 10.1016/j.cell.2022.11.001 10.1016/j.bj.2023.02.001 10.1056/NEJMoa2002788 10.3390/cancers13184561 10.1080/2162402X.2020.1715767 10.1038/ncomms11762 10.1038/s41418-019-0467-6 10.1152/physrev.00020.2018 10.1073/pnas.2021174118 10.1038/s41467-020-20513-5 10.1038/s41580-023-00585-z 10.1172/JCI145071 10.1038/ncb3342 10.4161/auto.1.3.2017 10.1016/j.ijrobp.2019.08.009 10.1016/j.cell.2022.12.036 10.3389/fonc.2020.589908 10.1016/j.semcancer.2022.02.005 10.1038/emboj.2009.164 10.1126/scitranslmed.aaz6314 10.18632/aging.100897 10.11613/BM.2019.030501 10.7150/thno.55672 10.1038/s41467-023-36878-2 10.1016/j.arr.2020.101156 10.1016/0014-4827(61)90192-6 10.1038/s41568-019-0156-2 10.1097/SLA.0000000000004037 10.1038/s42255-021-00483-8 10.1016/j.jncc.2023.09.001 10.1038/s41586-018-0784-9 10.1093/eurheartj/ehz919 10.1158/2326-6066.CIR-21-0559 10.3389/fmolb.2022.919274 10.5812/hepatmon.114381 10.2174/1389450114666140106101412 10.1111/j.1440-1746.2004.03467.x 10.1016/j.cell.2013.05.039 10.1146/annurev-genet-102808-114910 10.1038/s41571-022-00668-4 10.1038/labinvest.3700673 10.1038/s41568-019-0222-9 10.1016/j.coi.2012.12.003 10.1016/j.cmet.2022.11.001 10.1016/j.cell.2011.02.013 10.1111/j.1600-065X.2007.00566.x 10.1016/j.celrep.2021.108779 10.1158/0008-5472.CAN-05-1215 10.1136/jitc-2020-000978 10.1016/j.immuni.2019.06.025 10.1186/s12943-021-01489-2 10.1002/JLB.MR0718-299R 10.1016/j.tcb.2015.10.005 10.1158/2159-8290.CD-22-0523 10.1136/jitc-2020-001536 10.1002/1878-0261.12807 10.3389/fendo.2018.00790 10.1016/j.canlet.2022.215804 10.1080/21645515.2018.1431598 10.1080/15548627.2015.1121361 10.1016/j.redox.2022.102383 10.1101/gad.343129.120 10.1158/2159-8290.CD-19-0400 |
| ContentType | Journal Article |
| Copyright | 2025 Elsevier B.V. Copyright © 2025 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2025 Elsevier B.V. – notice: Copyright © 2025 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.critrevonc.2025.104628 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-0461 |
| ExternalDocumentID | 39864532 10_1016_j_critrevonc_2025_104628 S1040842825000162 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SSH SSZ T5K UDS W2D WUQ Z5R ~G- AACTN RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c376t-5dd8b80b96643de07848e0168ab0b57e322e641407820220394eee8c322e7e83 |
| IEDL.DBID | .~1 |
| ISSN | 1040-8428 1879-0461 |
| IngestDate | Mon Jul 21 09:51:15 EDT 2025 Tue May 06 01:31:28 EDT 2025 Tue Jul 01 05:26:03 EDT 2025 Sat Mar 22 15:53:26 EDT 2025 Tue Aug 26 19:39:30 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Inflammation Tumor immune escape Autophagy Immunotherapy Cellular senescence |
| Language | English |
| License | Copyright © 2025 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c376t-5dd8b80b96643de07848e0168ab0b57e322e641407820220394eee8c322e7e83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 39864532 |
| PQID | 3160068837 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3160068837 pubmed_primary_39864532 crossref_primary_10_1016_j_critrevonc_2025_104628 elsevier_sciencedirect_doi_10_1016_j_critrevonc_2025_104628 elsevier_clinicalkey_doi_10_1016_j_critrevonc_2025_104628 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | April 2025 2025-04-00 2025-Apr 20250401 |
| PublicationDateYYYYMMDD | 2025-04-01 |
| PublicationDate_xml | – month: 04 year: 2025 text: April 2025 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Critical reviews in oncology/hematology |
| PublicationTitleAlternate | Crit Rev Oncol Hematol |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Fagiani, Di Marino, Romagnoli, Travelli, Voltan, Di Cesare Mannelli, Racchi, Govoni, Lanni (bib45) 2022; 7 Hanahan, Weinberg (bib53) 2011; 144 Montes, Chapoval, Nelson, Orhue, Zhang, Schulze, Strome, Gastman (bib90) 2008; 68 Salam, Saliou, Bielle, Bertrand, Antoniewski, Carpentier, Alentorn, Capelle, Sanson, Huillard, Bellenger, Guégan, Le Roux (bib112) 2023; 14 Hao, Zhao, Zhou, Liu, Fukumoto, Gabrilovich, Zhang (bib54) 2021; 24 Di Micco, Krizhanovsky, Baker, di Fagagna (bib36) 2021; 22 López-Otín, Pietrocola, Roiz-Valle, Galluzzi, Kroemer (bib85) 2023; 35 Chen, Hsu, Chang, Tan, Lan, Zhou, Spring, Lang, Wang, DePinho (bib18) 2020; 10 Xiang, Fu, Zhao, Miao, Zhang, Ma, Liu, Zhang, Qu (bib133) 2021; 11 Shay (bib117) 2016; 6 Stojanović, Fiedler, Bauersachs, Thum, Sedding (bib121) 2020; 41 Alvarez, Dunai, Khuat, Aguilar, Barao, Murphy (bib5) 2020; 12 Marrero-Rodríguez, Taniguchi-Ponciano, Kerbel, Cano-Zaragoza, Remba-Shapiro, Silva-Román, Vela-Patiño, Andonegui-Elguera, Valenzuela-Perez, Mercado (bib89) 2022; 24 Batlle, Massagué (bib9) 2019; 50 De Blander, Morel, Senaratne, Ouzounova, Puisieux (bib28) 2021; 13 Dodig, Čepelak, Pavić (bib41) 2019; 29 Zhang, Qiao, Liu, Han, Liu, Wang, Xie, Tang, Wang, Meng, Ye, He, Chen, Chen (bib144) 2022; 54 Yasuda, Koiwa, Yonemura, Miyake, Kariya, Kubota, Yokomizo-Nakano, Yasuda-Yoshihara, Uchihara, Itoyama, Bu, Fu, Arima, Izumi, Iwagami, Eto, Iwatsuki, Baba, Yoshida, Ohguchi, Okada, Matsusaki, Sashida, Takahashi, Tan, Baba, Ishimoto (bib137) 2021; 34 Dmello, Zhao, Chen, Gould, Castro, Arrieta, Zhang, Kim, Kanojia, Zhang, Miska, Yeeravalli, Habashy, Saganty, Kang, Fares, Liu, Dunn, Bartom, Schipma, Hsu, Alghamri, Lesniak, Heimberger, Rabadan, Lee-Chang, Sonabend (bib40) 2023; 14 Zhao, Hu, Xu, Zeng, Xi, Chen, Wu, Hu, Zhong (bib145) 2022; 9 Montes, Nielsen, Maglieri, Jacobsen, Højfeldt, Agrawal-Singh, Hansen, Helin, van de Werken, Pedersen, Lund (bib91) 2015; 6 Debnath, Gammoh, Ryan (bib31) 2023; 24 Calcinotto, Kohli, Zagato, Pellegrini, Demaria, Alimonti (bib13) 2019; 99 Chou, Kaller, Jaeckel, Rokavec, Hermeking (bib23) 2022; 21 Barnes, de Rosa, Thosar, Detwiler, Roginskaya, Van Houten, Bruchez, Stewart-Ornstein, Opresko (bib8) 2022; 29 Hood, Amir (bib63) 2017; 127 Zhao, Simon, Seluanov, Gorbunova (bib146) 2023; 23 López-Otín, Blasco, Partridge, Serrano, Kroemer (bib83) 2013; 153 Thepmalee, Panya, Junking, Chieochansin, Yenchitsomanus (bib124) 2018; 14 Gardner, Humphry, Bennett, Clarke (bib49) 2015; 35 Greten, Grivennikov (bib51) 2019; 51 Crespo, Sun, Welling, Tian, Zou (bib25) 2013; 25 Hanahan (bib52) 2022; 12 Muñoz, Yannone, Daemen, Sun, Vakar-Lopez, Kawahara, Freund, Rodier, Wu, Desprez, Raulet, Nelson, van 't Veer, Campisi, Coppé (bib92) 2019; 5 Dong, Dai, Lin, Sheng, Li, Wang, Zhang, Jiang, Yin, Lu (bib42) 2023; 21 López-Otín, Blasco, Partridge, Serrano, Kroemer (bib84) 2023; 186 Wang, Johmura, Suzuki, Omori, Migita, Yamaguchi, Hatakeyama, Yamazaki, Shimizu, Imoto, Furukawa, Yoshimura, Nakanishi (bib130) 2022; 611 Yang, Liu, Hong, Zeng, Zhang (bib136) 2021; 9 Stagg, Johnstone, Smyth (bib120) 2007; 220 Nazio, Bordi, Cianfanelli, Locatelli, Cecconi (bib94) 2019; 26 Ruscetti, Morris, Mezzadra, Russell, Leibold, Romesser, Simon, Kulick, Ho, Fennell, Li, Norgard, Wilkinson, Alonso-Curbelo, Sridharan, Heller, de Stanchina, Stanger, Sherr, Lowe (bib110) 2020; 181 Barbosa, Grosso, Fader (bib7) 2018; 9 Campisi (bib14) 2013; 75 Schneider, Buzdin, Weber, Clavien, Borger (bib114) 2021; 13 Lv, Lv, Chen, Zong, Jiang, Ye, Cui, He, Xiang, Han, Tang, Yang, Wang (bib86) 2021; 33 Eggert, Wolter, Ji, Ma, Yevsa, Klotz, Medina-Echeverz, Longerich, Forgues, Reisinger, Heikenwalder, Wang, Zender, Greten (bib43) 2016; 30 Pansy, Uhl, Krstic, Szmyra, Fechter, Santiso, Thüminger, Greinix, Kargl, Prochazka, Feichtinger, Deutsch (bib97) 2021; 22 Schmitt, Wang, Demaria (bib113) 2022; 19 Sun, Feng, Chen, Zhang, Xie, Yang, Shao, Liu, Yang, Kong, Qu (bib122) 2013; 10 He, Klionsky (bib56) 2009; 43 Laberge, Sun, Orjalo, Patil, Freund, Zhou, Curran, Davalos, Wilson-Edell, Liu, Limbad, Demaria, Li, Hubbard, Ikeno, Javors, Desprez, Benz, Kapahi, Nelson, Campisi (bib70) 2015; 17 Liu, Zhou, Wang, Zhang, Zeng, Huang, Chen, Jiang, Lin, Qu, Xiong, Bai, Xia, Wang, Liu, Zhu, Xu, Dai, Guo, Wang, Chang, Zhang (bib82) 2020; 8 Cohn, Gasek, Kuchel, Xu (bib24) 2023; 33 Zeng, Hills, Ozono, Diffley (bib141) 2023; 186 Xuan, Hsu, Khan, Dunterman, Pang, Wainwright, Ahmed, Heimberger, Lesniak, Chen (bib135) 2022; 10 Burton, Stolzing (bib12) 2018; 43 Riley, June, Langer, Mitchell (bib107) 2019; 18 Bollard, Miguela, Ruiz de Galarreta, Venkatesh, Bian, Roberto, Tovar, Sia, Molina-Sánchez, Nguyen, Nakagawa, Llovet, Hoshida, Lujambio (bib11) 2017; 66 Lee, Kang, Han, Lee, Hwang, Lee, You, Min, Park, Ko, Gorospe, Lee (bib73) 2020; 27 Curtis, Bellet, Sassone-Corsi, O'Neill (bib27) 2014; 40 Deng, Terunuma, Nieda (bib32) 2021; 9 Gao, Liu, Lin, Wang, Wang, Si, Huang, Zhao, Sun, Peng (bib48) 2021; 9 Powles, Park, Voog, Caserta, Valderrama, Gurney, Kalofonos, Radulović, Demey, Ullén, Loriot, Sridhar, Tsuchiya, Kopyltsov, Sternberg, Bellmunt, Aragon-Ching, Petrylak, Laliberte, Wang, Huang, Davis, Fowst, Costa, Blake-Haskins, di Pietro, Grivas (bib101) 2020; 383 Uyar, Palmer, Kowald, Murua Escobar, Barrantes, Möller, Akalin, Fuellen (bib126) 2020; 64 Yin, Patten, Gough, Goncalves, Chan, Olan, Cassidy, Poblocka, Zhu, Lun, Schuijs, Young, Martinez-Jimenez, Halim, Shetty, Narita, Hoare (bib140) 2022; 36 Pardoll (bib98) 2012; 12 Onorati, Havas, Lin, Rajagopal, Sen, Adams, Dou (bib95) 2022; 42 Aiello, Fedele, Román, Marpegan, Caldart, Chiesa, Golombek, Finkielstein, Paladino (bib3) 2020; 6 Marin, Serrano, Pietrocola (bib88) 2023; 12 Ruhland, Loza, Capietto, Luo, Knolhoff, Flanagan, Belt, Alspach, Leahy, Luo, Schaffer, Edwards, Longmore, Faccio, DeNardo, Stewart (bib109) 2016; 7 Chen, Gong, Shen, Liu, Fu, Dai, Rehman, Tang, Liu (bib19) 2021; 12 Huda, Khambu, Liu, Nakatsumi, Yan, Chen, Ma, Dong, Nakayama, Yin (bib65) 2022; 14 Sheng, Kohno, Okada, Okahashi, Teranishi, Matsuda, Shimizu, Linn, Nagatani, Yamamura, Harada, Horike, Inoue, Yano, Kumar, Kitajima, Ajioka, Takahashi (bib118) 2021; 74 Wiley, Campisi (bib132) 2021; 3 Janelle, Neault, Lebel, De Sousa, Boulet, Durrieu, Carli, Muzac, Lemieux, Labrecque, Melichar, Mallette, Delisle (bib66) 2021; 12 Song, Wang, Huang (bib119) 2023; 3 Ye, Baer, Faget, Morikis, Ren, Melam, Delgado, Luo, Bagchi, Belle, Campos, Friedman, Veis, Knudsen, Witkiewicz, Powers, Longmore, DeNardo, Stewart (bib138) 2024; 14 Chen, Wang, Li, Xu, Fanzheng, Zhang, Liu (bib16) 2023; 13 Yi, Zheng, Niu, Zhu, Ge, Wu (bib139) 2022; 21 Deng, Xia, Zhao, Zhao, Martinez, Yin, Yao, Hang, Wu, Zhang, Yu, Xia, Yao, Zhao, Sun, Ying, Hung, Ma (bib34) 2021; 12 Ren, Li, Pei, Lian, Li, Peng, Liu, Guo, Wang, Han, Zhang, Wang, Li, Jiang, Li, Tan, Peng, Hu, Xiao, Li, Lin, Qin (bib106) 2022; 132 Lee, Lee, Camus, Ghim, Yang, Oh, Ha, Lane, Song (bib72) 2009; 28 Chen, Gong, Shao, Shi, Zhang, Dong, Shi, Shen, Qin, Jiang, Guo (bib20) 2022; 81 Rivellini, Porrello, Dina, Mrakic-Sposta, Vezzoli, Bacigaluppi, Gullotta, Chaabane, Leocani, Marenna, Colombo, Farina, Newcombe, Nave, Pardi, Quattrini, Previtali (bib108) 2022; 132 Levine, Kroemer (bib74) 2019; 176 Shafi, McNair, McCann, Alshalalfa, Shostak, Severson, Zhu, Bergman, Gordon, Mandigo, Chand, Gallagher, Dylgjeri, Laufer, Vasilevskaya, Schiewer, Brunner, Feng, Zwart, Knudsen (bib116) 2021; 12 Acosta, Banito, Wuestefeld, Georgilis, Janich, Morton, Athineos, Kang, Lasitschka, Andrulis, Pascual, Morris, Khan, Jin, Dharmalingam, Snijders, Carroll, Capper, Pritchard, Inman, Longerich, Sansom, Benitah, Zender, Gil (bib2) 2013; 15 Reimann, Schrezenmeier, Richter-Pechanska, Dolnik, Hick, Schleich, Cai, Fan, Lohneis, Maßwig, Denker, Busse, Knittel, Flümann, Childs, Childs, Gätjens-Sanchez, Bullinger, Rosenwald, Reinhardt, Schmitt (bib105) 2021; 137 Zhou, Bei, Li, Zhu, Tu (bib148) 2021; 21 Herranz, Gallage, Mellone, Wuestefeld, Klotz, Hanley, Raguz, Acosta, Innes, Banito, Georgilis, Montoya, Wolter, Dharmalingam, Faull, Carroll, Martínez-Barbera, Cutillas, Reisinger, Heikenwalder, Miller, Withers, Zender, Thomas, Gil (bib58) 2015; 17 Huang, Li, Yuan, Zhao, Wang, Li, Li, Lin, Zhang, Wang, Li, Dong, Li, Liu, Huang, Huang (bib64) 2019; 26 Sagiv, Burton, Moshayev, Vadai, Wensveen, Ben-Dor, Golani, Polic, Krizhanovsky (bib111) 2016; 8 Xu, Long, Zhu, Fu, Zhang, Han, Qian, Guo, Xu, Cao, Chin, Coppé, Lam, Campisi, Sun (bib134) 2019; 18 Fane, Weeraratna (bib46) 2020; 20 Birch, Gil (bib10) 2020; 34 Cuervo, Bergamini, Brunk, Dröge, Ffrench, Terman (bib26) 2005; 1 Rao, Jackson (bib104) 2016; 2 Tovar, Graves, Packman, Filipovic, Higgins, Xia, Tardell, Garrido, Lee, Kolinsky, To, Linn, Podlaski, Wovkulich, Vu, Vassilev (bib125) 2013; 73 Herranz, Gil (bib59) 2018; 128 Zhang, Pitcher, Yousefzadeh, Niedernhofer, Robbins, Zhu (bib143) 2022; 132 Liu, Lomeli, Kron (bib80) 2024; 13 Chen, Ho, Mezzadra, Adrover, Smolkin, Zhu, Woess, Bernstein, Schmitt, Fong, Luan, Wuest, Tian, Li, Broderick, Hendrickson, Egeblad, Chen, Alonso-Curbelo, Lowe (bib17) 2023; 13 Di Mitri, Alimonti (bib37) 2016; 26 Pereira, Devine, Vukmanovic-Stejic, Chambers, Subramanian, Patel, Virasami, Sebire, Kinsler, Valdovinos, LeSaux, Passos, Antoniou, Rustin, Campisi, Akbar (bib100) 2019; 10 Sung, Kim, Kim, Choi (bib123) 2021; 150 Prata, Ovsyannikova, Tchkonia, Kirkland (bib102) 2018; 40 Herbst, Giaccone, de Marinis, Reinmuth, Vergnenegre, Barrios, Morise, Felip, Andric, Geater, Özgüroğlu, Zou, Sandler, Enquist, Komatsubara, Deng, Kuriki, Wen, McCleland, Mocci, Jassem, Spigel (bib57) 2020; 383 Hirschhorn, Budhu, Kraehenbuehl, Gigoux, Schröder, Chow, Ricca, Gasmi, De Henau, Mangarin, Li, Hamadene, Flamar, Choi, Cortez, Liu, Holland, Schad, Schulze, Betof Warner, Hollmann, Arora, Panageas, Rizzuto, Duhen, Weinberg, Spencer, Ng, He, Albrengues, Redmond, Egeblad, Wolchok, Merghoub (bib60) 2023; 186 Liu, Si, Bagley, Ma, Zhang, Tao, Shaw, Peng (bib79) 2022; 10 Cheng, Kang, Zhao, Wu (bib21) 2024; 17 Antonangeli, Zingoni, Soriani, Santoni (bib6) 2019; 105 Jin, Duan, Li, Zhou, Zou, Xie (bib67) Chen (10.1016/j.critrevonc.2025.104628_bib16) 2023; 13 Deng (10.1016/j.critrevonc.2025.104628_bib32) 2021; 9 Ren (10.1016/j.critrevonc.2025.104628_bib106) 2022; 132 Alique (10.1016/j.critrevonc.2025.104628_bib4) 2020; 9 Kang (10.1016/j.critrevonc.2025.104628_bib68) 2016; 12 Rivellini (10.1016/j.critrevonc.2025.104628_bib108) 2022; 132 Song (10.1016/j.critrevonc.2025.104628_bib119) 2023; 3 Hayflick (10.1016/j.critrevonc.2025.104628_bib55) 1961; 25 Zhou (10.1016/j.critrevonc.2025.104628_bib148) 2021; 21 Shay (10.1016/j.critrevonc.2025.104628_bib117) 2016; 6 Huda (10.1016/j.critrevonc.2025.104628_bib65) 2022; 14 Hanahan (10.1016/j.critrevonc.2025.104628_bib53) 2011; 144 Chen (10.1016/j.critrevonc.2025.104628_bib20) 2022; 81 Liu (10.1016/j.critrevonc.2025.104628_bib77) 2020; 10 Rao (10.1016/j.critrevonc.2025.104628_bib104) 2016; 2 Marin (10.1016/j.critrevonc.2025.104628_bib88) 2023; 12 Di Micco (10.1016/j.critrevonc.2025.104628_bib36) 2021; 22 Wiley (10.1016/j.critrevonc.2025.104628_bib132) 2021; 3 Liu (10.1016/j.critrevonc.2025.104628_bib81) 2021; 20 Sheng (10.1016/j.critrevonc.2025.104628_bib118) 2021; 74 Wang (10.1016/j.critrevonc.2025.104628_bib128) 2022; 89 Muñoz (10.1016/j.critrevonc.2025.104628_bib92) 2019; 5 Giannoula (10.1016/j.critrevonc.2025.104628_bib50) 2023 He (10.1016/j.critrevonc.2025.104628_bib56) 2009; 43 Debnath (10.1016/j.critrevonc.2025.104628_bib31) 2023; 24 Pansy (10.1016/j.critrevonc.2025.104628_bib97) 2021; 22 Crespo (10.1016/j.critrevonc.2025.104628_bib25) 2013; 25 Alvarez (10.1016/j.critrevonc.2025.104628_bib5) 2020; 12 Zhang (10.1016/j.critrevonc.2025.104628_bib142) 2022; 275 Huang (10.1016/j.critrevonc.2025.104628_bib64) 2019; 26 Nagai (10.1016/j.critrevonc.2025.104628_bib93) 2021; 22 Campisi (10.1016/j.critrevonc.2025.104628_bib14) 2013; 75 Fane (10.1016/j.critrevonc.2025.104628_bib46) 2020; 20 Li (10.1016/j.critrevonc.2025.104628_bib75) 2022; 22 Zhong (10.1016/j.critrevonc.2025.104628_bib147) 2022; 13 Tovar (10.1016/j.critrevonc.2025.104628_bib125) 2013; 73 Barbosa (10.1016/j.critrevonc.2025.104628_bib7) 2018; 9 Uyar (10.1016/j.critrevonc.2025.104628_bib126) 2020; 64 Lee (10.1016/j.critrevonc.2025.104628_bib73) 2020; 27 Pardoll (10.1016/j.critrevonc.2025.104628_bib98) 2012; 12 Yasuda (10.1016/j.critrevonc.2025.104628_bib137) 2021; 34 Stagg (10.1016/j.critrevonc.2025.104628_bib120) 2007; 220 Ding (10.1016/j.critrevonc.2025.104628_bib39) 2019; 105 Birch (10.1016/j.critrevonc.2025.104628_bib10) 2020; 34 Zeng (10.1016/j.critrevonc.2025.104628_bib141) 2023; 186 Hirschhorn (10.1016/j.critrevonc.2025.104628_bib60) 2023; 186 Segeren (10.1016/j.critrevonc.2025.104628_bib115) 2022; 544 Fujiwara (10.1016/j.critrevonc.2025.104628_bib47) 2004; 19 Levine (10.1016/j.critrevonc.2025.104628_bib74) 2019; 176 Calcinotto (10.1016/j.critrevonc.2025.104628_bib13) 2019; 99 Wang (10.1016/j.critrevonc.2025.104628_bib130) 2022; 611 Liu (10.1016/j.critrevonc.2025.104628_bib78) 2021; 13 Burton (10.1016/j.critrevonc.2025.104628_bib12) 2018; 43 Di Mitri (10.1016/j.critrevonc.2025.104628_bib37) 2016; 26 Hao (10.1016/j.critrevonc.2025.104628_bib54) 2021; 24 Montes (10.1016/j.critrevonc.2025.104628_bib90) 2008; 68 Hofmann (10.1016/j.critrevonc.2025.104628_bib61) 2019; 115 Xuan (10.1016/j.critrevonc.2025.104628_bib135) 2022; 10 Salam (10.1016/j.critrevonc.2025.104628_bib112) 2023; 14 Sung (10.1016/j.critrevonc.2025.104628_bib123) 2021; 150 Marin (10.1016/j.critrevonc.2025.104628_bib87) 2023; 13 Deng (10.1016/j.critrevonc.2025.104628_bib34) 2021; 12 López-Otín (10.1016/j.critrevonc.2025.104628_bib83) 2013; 153 Janelle (10.1016/j.critrevonc.2025.104628_bib66) 2021; 12 Cheng (10.1016/j.critrevonc.2025.104628_bib21) 2024; 17 Dmello (10.1016/j.critrevonc.2025.104628_bib40) 2023; 14 Kumari (10.1016/j.critrevonc.2025.104628_bib69) 2021; 9 Nazio (10.1016/j.critrevonc.2025.104628_bib94) 2019; 26 Chou (10.1016/j.critrevonc.2025.104628_bib23) 2022; 21 Schneider (10.1016/j.critrevonc.2025.104628_bib114) 2021; 13 Acosta (10.1016/j.critrevonc.2025.104628_bib2) 2013; 15 Liu (10.1016/j.critrevonc.2025.104628_bib80) 2024; 13 De Cecco (10.1016/j.critrevonc.2025.104628_bib29) 2019; 566 Liu (10.1016/j.critrevonc.2025.104628_bib82) 2020; 8 Yin (10.1016/j.critrevonc.2025.104628_bib140) 2022; 36 Herranz (10.1016/j.critrevonc.2025.104628_bib58) 2015; 17 Marrero-Rodríguez (10.1016/j.critrevonc.2025.104628_bib89) 2022; 24 Herranz (10.1016/j.critrevonc.2025.104628_bib59) 2018; 128 Paz-Ares (10.1016/j.critrevonc.2025.104628_bib99) 2020; 31 Abdisalaam (10.1016/j.critrevonc.2025.104628_bib1) 2020; 295 Ou (10.1016/j.critrevonc.2025.104628_bib96) 2021; 15 Hood (10.1016/j.critrevonc.2025.104628_bib63) 2017; 127 Deng (10.1016/j.critrevonc.2025.104628_bib33) 2007; 87 Xu (10.1016/j.critrevonc.2025.104628_bib134) 2019; 18 Zhao (10.1016/j.critrevonc.2025.104628_bib145) 2022; 9 Xiang (10.1016/j.critrevonc.2025.104628_bib133) 2021; 11 Batlle (10.1016/j.critrevonc.2025.104628_bib9) 2019; 50 Lee (10.1016/j.critrevonc.2025.104628_bib71) 2024; 32 Li (10.1016/j.critrevonc.2025.104628_bib76) 2023; 8 Dong (10.1016/j.critrevonc.2025.104628_bib42) 2023; 21 López-Otín (10.1016/j.critrevonc.2025.104628_bib84) 2023; 186 López-Otín (10.1016/j.critrevonc.2025.104628_bib85) 2023; 35 Barnes (10.1016/j.critrevonc.2025.104628_bib8) 2022; 29 Cao (10.1016/j.critrevonc.2025.104628_bib15) 2021; 118 Dikmen (10.1016/j.critrevonc.2025.104628_bib38) 2005; 65 Stojanović (10.1016/j.critrevonc.2025.104628_bib121) 2020; 41 Riley (10.1016/j.critrevonc.2025.104628_bib107) 2019; 18 Hanahan (10.1016/j.critrevonc.2025.104628_bib52) 2022; 12 Sun (10.1016/j.critrevonc.2025.104628_bib122) 2013; 10 Fagiani (10.1016/j.critrevonc.2025.104628_bib45) 2022; 7 Thepmalee (10.1016/j.critrevonc.2025.104628_bib124) 2018; 14 Qu (10.1016/j.critrevonc.2025.104628_bib103) 2023; 120 Ruhland (10.1016/j.critrevonc.2025.104628_bib109) 2016; 7 Eggert (10.1016/j.critrevonc.2025.104628_bib43) 2016; 30 Montes (10.1016/j.critrevonc.2025.104628_bib91) 2015; 6 Liu (10.1016/j.critrevonc.2025.104628_bib79) 2022; 10 Chen (10.1016/j.critrevonc.2025.104628_bib19) 2021; 12 Shafi (10.1016/j.critrevonc.2025.104628_bib116) 2021; 12 Pereira (10.1016/j.critrevonc.2025.104628_bib100) 2019; 10 Powles (10.1016/j.critrevonc.2025.104628_bib101) 2020; 383 Zhang (10.1016/j.critrevonc.2025.104628_bib144) 2022; 54 Ye (10.1016/j.critrevonc.2025.104628_bib138) 2024; 14 Yi (10.1016/j.critrevonc.2025.104628_bib139) 2022; 21 Onorati (10.1016/j.critrevonc.2025.104628_bib95) 2022; 42 Reimann (10.1016/j.critrevonc.2025.104628_bib105) 2021; 137 Yang (10.1016/j.critrevonc.2025.104628_bib136) 2021; 9 Hong (10.1016/j.critrevonc.2025.104628_bib62) 2014; 15 Herbst (10.1016/j.critrevonc.2025.104628_bib57) 2020; 383 Faget (10.1016/j.critrevonc.2025.104628_bib44) 2019; 19 Vahl (10.1016/j.critrevonc.2025.104628_bib127) 2017; 117 Cohn (10.1016/j.critrevonc.2025.104628_bib24) 2023; 33 Aiello (10.1016/j.critrevonc.2025.104628_bib3) 2020; 6 Prata (10.1016/j.critrevonc.2025.104628_bib102) 2018; 40 Cuervo (10.1016/j.critrevonc.2025.104628_bib26) 2005; 1 De Blander (10.1016/j.critrevonc.2025.104628_bib28) 2021; 13 Dodig (10.1016/j.critrevonc.2025.104628_bib41) 2019; 29 Jin (10.1016/j.critrevonc.2025.104628_bib67) 2024; 5 Gardner (10.1016/j.critrevonc.2025.104628_bib49) 2015; 35 Wang (10.1016/j.critrevonc.2025.104628_bib129) 2016; 18 Lv (10.1016/j.critrevonc.2025.104628_bib86) 2021; 33 Sagiv (10.1016/j.critrevonc.2025.104628_bib111) 2016; 8 Schmitt (10.1016/j.critrevonc.2025.104628_bib113) 2022; 19 Zhao (10.1016/j.critrevonc.2025.104628_bib146) 2023; 23 Chen (10.1016/j.critrevonc.2025.104628_bib18) 2020; 10 Zhang (10.1016/j.critrevonc.2025.104628_bib143) 2022; 132 Chen (10.1016/j.critrevonc.2025.104628_bib17) 2023; 13 Greten (10.1016/j.critrevonc.2025.104628_bib51) 2019; 51 Lee (10.1016/j.critrevonc.2025.104628_bib72) 2009; 28 Gao (10.1016/j.critrevonc.2025.104628_bib48) 2021; 9 Curtis (10.1016/j.critrevonc.2025.104628_bib27) 2014; 40 De Martino (10.1016/j.critrevonc.2025.104628_bib30) 2020; 9 Bollard (10.1016/j.critrevonc.2025.104628_bib11) 2017; 66 Antonangeli (10.1016/j.critrevonc.2025.104628_bib6) 2019; 105 Dhatchinamoorthy (10.1016/j.critrevonc.2025.104628_bib35) 2021; 12 Laberge (10.1016/j.critrevonc.2025.104628_bib70) 2015; 17 Wang (10.1016/j.critrevonc.2025.104628_bib131) 2022; 23 Chibaya (10.1016/j.critrevonc.2025.104628_bib22) 2022; 86 Ruscetti (10.1016/j.critrevonc.2025.104628_bib110) 2020; 181 |
| References_xml | – volume: 43 start-page: 67 year: 2009 end-page: 93 ident: bib56 article-title: Regulation mechanisms and signaling pathways of autophagy publication-title: Annu Rev. Genet – volume: 64 year: 2020 ident: bib126 article-title: Single-cell analyses of aging, inflammation and senescence publication-title: Ageing Res Rev. – volume: 73 start-page: 2587 year: 2013 end-page: 2597 ident: bib125 article-title: MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models publication-title: Cancer Res – volume: 99 start-page: 1047 year: 2019 end-page: 1078 ident: bib13 article-title: Cellular senescence: aging, cancer, and injury publication-title: Physiol. Rev. – volume: 137 start-page: 2785 year: 2021 end-page: 2799 ident: bib105 article-title: Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas publication-title: Blood – volume: 41 start-page: 2983 year: 2020 end-page: 2996 ident: bib121 article-title: Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis publication-title: Eur. Heart J. – volume: 5 start-page: 14 year: 2019 ident: bib92 article-title: Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging publication-title: JCI Insight – volume: 17 start-page: 54 year: 2024 ident: bib21 article-title: Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer publication-title: J. Hematol. Oncol. – volume: 29 start-page: 639 year: 2022 end-page: 652 ident: bib8 article-title: Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening publication-title: Nat. Struct. Mol. Biol. – volume: 9 start-page: 557 year: 2021 ident: bib32 article-title: Immunosurveillance of cancer and viral infections with regard to alterations of human NK cells originating from lifestyle and aging publication-title: Biomedicines – volume: 86 start-page: 827 year: 2022 end-page: 845 ident: bib22 article-title: Senescence and the tumor-immune landscape: Implications for cancer immunotherapy publication-title: Semin Cancer Biol. – volume: 10 year: 2020 ident: bib77 article-title: Hepatocellular senescence: immunosurveillance and future senescence-induced therapy in hepatocellular carcinoma publication-title: Front Oncol. – volume: 132 year: 2022 ident: bib108 article-title: JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice publication-title: J. Clin. Invest – volume: 40 start-page: 178 year: 2014 end-page: 186 ident: bib27 article-title: Circadian clock proteins and immunity publication-title: Immunity – volume: 24 start-page: 177 year: 2022 end-page: 190 ident: bib89 article-title: The hallmarks of cancer… in pituitary tumors? publication-title: Rev. Endocr. Metab. Disord. – volume: 22 year: 2021 ident: bib93 article-title: Immunomodulation by Inflammation during liver and gastrointestinal tumorigenesis and aging publication-title: Int J. Mol. Sci. – volume: 34 year: 2021 ident: bib137 article-title: Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination publication-title: Cell Rep. – volume: 35 start-page: 1963 year: 2015 end-page: 1974 ident: bib49 article-title: Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 13 start-page: 432 year: 2023 end-page: 453 ident: bib17 article-title: Senescence rewires microenvironment sensing to facilitate antitumor immunity publication-title: Cancer Discov. – volume: 8 start-page: 328 year: 2016 end-page: 344 ident: bib111 article-title: NKG2D ligands mediate immunosurveillance of senescent cells publication-title: Aging (Albany NY) – volume: 17 start-page: 1049 year: 2015 end-page: 1061 ident: bib70 article-title: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation publication-title: Nat. Cell Biol. – volume: 132 year: 2022 ident: bib143 article-title: Cellular senescence: a key therapeutic target in aging and diseases publication-title: J. Clin. Invest – volume: 19 start-page: 619 year: 2022 end-page: 636 ident: bib113 article-title: Senescence and cancer - role and therapeutic opportunities publication-title: Nat. Rev. Clin. Oncol. – volume: 50 start-page: 924 year: 2019 end-page: 940 ident: bib9 article-title: Transforming growth factor-β signaling in immunity and cancer publication-title: Immunity – volume: 25 start-page: 214 year: 2013 end-page: 221 ident: bib25 article-title: T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment publication-title: Curr. Opin. Immunol. – volume: 21 year: 2021 ident: bib148 article-title: TLR3 mediates senescence and immunosurveillance of hepatic stellate cells publication-title: Hepat. Mon. – volume: 32 start-page: 4235 year: 2024 end-page: 4255 ident: bib71 article-title: PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders publication-title: Mol. Ther.: J. Am. Soc. Gene Ther. – volume: 75 start-page: 685 year: 2013 end-page: 705 ident: bib14 article-title: Aging, cellular senescence, and cancer publication-title: Annu Rev. Physiol. – volume: 11 start-page: 4929 year: 2021 end-page: 4944 ident: bib133 article-title: Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2 publication-title: Theranostics – volume: 566 start-page: 73 year: 2019 end-page: 78 ident: bib29 article-title: L1 drives IFN in senescent cells and promotes age-associated inflammation publication-title: Nature – volume: 105 start-page: 861 year: 2019 end-page: 874 ident: bib39 article-title: BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition publication-title: Int J. Radiat. Oncol. Biol. Phys. – volume: 5 year: 2024 ident: bib67 article-title: Cellular senescence in cancer: molecular mechanisms and therapeutic targets – volume: 43 start-page: 17 year: 2018 end-page: 25 ident: bib12 article-title: Cellular senescence: Immunosurveillance and future immunotherapy publication-title: Ageing Res Rev. – volume: 181 start-page: 424 year: 2020 end-page: 441 ident: bib110 article-title: Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer publication-title: Cell – volume: 7 start-page: 41 year: 2022 ident: bib45 article-title: Molecular regulations of circadian rhythm and implications for physiology and diseases publication-title: Signal Transduct. Target Ther. – volume: 220 start-page: 82 year: 2007 end-page: 101 ident: bib120 article-title: From cancer immunosurveillance to cancer immunotherapy publication-title: Immunol. Rev. – volume: 12 start-page: 31 year: 2022 end-page: 46 ident: bib52 article-title: Hallmarks of cancer: new dimensions publication-title: Cancer Discov. – volume: 12 year: 2021 ident: bib66 article-title: p16(INK4a) regulates cellular senescence in PD-1-expressing human T cells publication-title: Front Immunol. – volume: 24 start-page: 560 year: 2023 end-page: 575 ident: bib31 article-title: Autophagy and autophagy-related pathways in cancer publication-title: Nat. Rev. Mol. Cell Biol. – volume: 51 start-page: 27 year: 2019 end-page: 41 ident: bib51 article-title: Inflammation and cancer: triggers, mechanisms, and consequences publication-title: Immunity – volume: 275 start-page: e626 year: 2022 end-page: e635 ident: bib142 article-title: Poor clinical outcomes and immunoevasive contexture in intratumoral IL-10-producing macrophages enriched gastric cancer patients publication-title: Ann. Surg. – volume: 12 start-page: 401 year: 2021 ident: bib116 article-title: The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair publication-title: Nat. Commun. – volume: 24 year: 2021 ident: bib54 article-title: Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype publication-title: iScience – volume: 74 start-page: 1971 year: 2021 end-page: 1993 ident: bib118 article-title: Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy publication-title: Hepatology – volume: 105 start-page: 1275 year: 2019 end-page: 1283 ident: bib6 article-title: Senescent cells: Living or dying is a matter of NK cells publication-title: J. Leukoc. Biol. – volume: 12 year: 2021 ident: bib35 article-title: Cancer immune evasion through loss of MHC class I antigen presentation publication-title: Front Immunol. – volume: 29 year: 2019 ident: bib41 article-title: Hallmarks of senescence and aging publication-title: Biochem Med (Zagreb) – volume: 89 start-page: 31 year: 2022 end-page: 40 ident: bib128 article-title: Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of CDK4/6-Cyclin D-Rb pathway publication-title: Cancer Chemother. Pharm. – volume: 26 start-page: 516 year: 2019 end-page: 530 ident: bib64 article-title: The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21 publication-title: Cell Death Differ. – volume: 127 start-page: 437 year: 2017 end-page: 446 ident: bib63 article-title: The aging clock: circadian rhythms and later life publication-title: J. Clin. Invest – volume: 25 start-page: 585 year: 1961 end-page: 621 ident: bib55 article-title: The serial cultivation of human diploid cell strains publication-title: Exp. Cell Res. – volume: 33 start-page: 9 year: 2023 end-page: 17 ident: bib24 article-title: The heterogeneity of cellular senescence: insights at the single-cell level publication-title: Trends Cell Biol. – volume: 9 year: 2020 ident: bib30 article-title: Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy publication-title: Oncoimmunology – volume: 2 start-page: 676 year: 2016 end-page: 687 ident: bib104 article-title: SASP: tumor suppressor or promoter? yes! publication-title: Trends Cancer – volume: 9 year: 2022 ident: bib145 article-title: Comprehensive Pan-cancer analysis of senescence with cancer prognosis and immunotherapy publication-title: Front Mol. Biosci. – volume: 10 year: 2022 ident: bib79 article-title: Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy publication-title: J. Immunother. Cancer – volume: 13 year: 2021 ident: bib114 article-title: Combination of antiretroviral drugs Zidovudine and Efavirenz impairs tumor growths in a mouse model of cancer publication-title: Viruses – volume: 115 start-page: 230 year: 2019 end-page: 242 ident: bib61 article-title: Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling publication-title: Cardiovasc Res – volume: 9 start-page: 790 year: 2018 ident: bib7 article-title: Hallmarks of aging: an autophagic perspective publication-title: Front Endocrinol. (Lausanne) – volume: 13 start-page: 410 year: 2023 end-page: 431 ident: bib87 article-title: Cellular senescence is immunogenic and promotes antitumor immunity publication-title: Cancer Discov. – volume: 383 start-page: 1328 year: 2020 end-page: 1339 ident: bib57 article-title: Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC publication-title: N. Engl. J. Med. – volume: 611 start-page: 358 year: 2022 end-page: 364 ident: bib130 article-title: Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes publication-title: Nature – volume: 12 start-page: 5938 year: 2021 end-page: 5949 ident: bib19 article-title: INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer publication-title: J. Cancer – volume: 23 start-page: 75 year: 2023 end-page: 89 ident: bib146 article-title: DNA damage and repair in age-related inflammation publication-title: Nat. Rev. Immunol. – volume: 6 year: 2020 ident: bib3 article-title: Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation publication-title: Sci. Adv. – volume: 12 year: 2023 ident: bib88 article-title: Cellular senescence enhances adaptive anticancer immunosurveillance publication-title: Oncoimmunology – volume: 40 year: 2018 ident: bib102 article-title: Senescent cell clearance by the immune system: emerging therapeutic opportunities publication-title: Semin Immunol. – volume: 6 start-page: 6967 year: 2015 ident: bib91 article-title: The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence publication-title: Nat. Commun. – volume: 10 start-page: 176 year: 2013 end-page: 182 ident: bib122 article-title: Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1 publication-title: Cell Mol. Immunol. – volume: 22 start-page: 75 year: 2021 end-page: 95 ident: bib36 article-title: Cellular senescence in ageing: from mechanisms to therapeutic opportunities publication-title: Nat. Rev. Mol. Cell Biol. – volume: 23 year: 2022 ident: bib131 article-title: Comprehensive assessment of cellular senescence in the tumor microenvironment publication-title: Brief. Bioinform – volume: 66 start-page: 1286 year: 2017 end-page: 1296 ident: bib11 article-title: Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma publication-title: Gut – volume: 26 start-page: 215 year: 2016 end-page: 226 ident: bib37 article-title: Non-cell-autonomous regulation of cellular senescence in cancer publication-title: Trends Cell Biol. – volume: 9 year: 2021 ident: bib136 article-title: The Paradoxical role of cellular senescence in cancer publication-title: Front Cell Dev. Biol. – volume: 150 year: 2021 ident: bib123 article-title: SIRT1 suppresses cellular senescence and inflammatory cytokine release in human dermal fibroblasts by promoting the deacetylation of NF-κB and activating autophagy publication-title: Exp. Gerontol. – volume: 27 start-page: 1844 year: 2020 end-page: 1861 ident: bib73 article-title: A novel long noncoding RNA Linc-ASEN represses cellular senescence through multileveled reduction of p21 expression publication-title: Cell Death Differ. – volume: 20 start-page: 89 year: 2020 end-page: 106 ident: bib46 article-title: How the ageing microenvironment influences tumour progression publication-title: Nat. Rev. Cancer – volume: 176 start-page: 11 year: 2019 end-page: 42 ident: bib74 article-title: Biological functions of autophagy genes: a disease perspective publication-title: Cell – volume: 18 year: 2019 ident: bib134 article-title: Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression publication-title: Aging Cell – volume: 12 start-page: 7041 year: 2021 ident: bib34 article-title: Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance publication-title: Nat. Commun. – volume: 3 start-page: 273 year: 2023 end-page: 278 ident: bib119 article-title: Therapy-induced senescent tumor cells in cancer relapse publication-title: J. Natl. Cancer Cent. – volume: 12 start-page: 898 year: 2016 end-page: 899 ident: bib68 article-title: How autophagy both activates and inhibits cellular senescence publication-title: Autophagy – volume: 14 start-page: 333 year: 2022 end-page: 355 ident: bib65 article-title: Senescence connects autophagy deficiency to inflammation and tumor progression in the liver publication-title: Cell Mol. Gastroenterol. Hepatol. – volume: 19 start-page: 439 year: 2019 end-page: 453 ident: bib44 article-title: Unmasking senescence: context-dependent effects of SASP in cancer publication-title: Nat. Rev. Cancer – volume: 12 start-page: 252 year: 2012 end-page: 264 ident: bib98 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat. Rev. Cancer – volume: 132 year: 2022 ident: bib106 article-title: Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity publication-title: J. Clin. Invest – volume: 13 start-page: 4561 year: 2021 ident: bib28 article-title: Cellular plasticity: a route to senescence exit and tumorigenesis publication-title: Cancers (Basel) – volume: 14 start-page: 1302 year: 2024 end-page: 1323 ident: bib138 article-title: Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression publication-title: Cancer Discov. – volume: 8 year: 2020 ident: bib82 article-title: Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer publication-title: J. Immunother. Cancer – volume: 15 start-page: 978 year: 2013 end-page: 990 ident: bib2 article-title: A complex secretory program orchestrated by the inflammasome controls paracrine senescence publication-title: Nat. Cell Biol. – volume: 9 year: 2021 ident: bib48 article-title: Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity publication-title: J. Immunother. Cancer – volume: 20 start-page: 105 year: 2021 ident: bib81 article-title: N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer publication-title: Mol. Cancer – volume: 19 start-page: 1121 year: 2004 end-page: 1127 ident: bib47 article-title: Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma publication-title: J. Gastroenterol. Hepatol. – volume: 14 start-page: 441 year: 2023 ident: bib112 article-title: Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma publication-title: Nat. Commun. – volume: 21 start-page: 28 year: 2022 ident: bib139 article-title: Combination strategies with PD-1/PD-L1 blockade: current advances and future directions publication-title: Mol. Cancer – volume: 186 start-page: 528 year: 2023 end-page: 542 ident: bib141 article-title: Cyclin E-induced replicative stress drives p53-dependent whole-genome duplication publication-title: Cell – volume: 17 start-page: 1205 year: 2015 end-page: 1217 ident: bib58 article-title: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype publication-title: Nat. Cell Biol. – volume: 295 start-page: 11144 year: 2020 end-page: 11160 ident: bib1 article-title: Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase publication-title: J. Biol. Chem. – volume: 35 start-page: 12 year: 2023 end-page: 35 ident: bib85 article-title: Meta-hallmarks of aging and cancer publication-title: Cell Metab. – volume: 120 year: 2023 ident: bib103 article-title: Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle publication-title: Proc. Natl. Acad. Sci. USA – volume: 9 start-page: 1 year: 2020 ident: bib4 article-title: Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging publication-title: Cells – volume: 18 start-page: 480 year: 2016 end-page: 490 ident: bib129 article-title: Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing publication-title: Nat. Cell Biol. – volume: 13 year: 2023 ident: bib16 article-title: LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A publication-title: Clin. Transl. Med. – volume: 81 start-page: 87 year: 2022 end-page: 99 ident: bib20 article-title: METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression publication-title: Ann. Rheum. Dis. – volume: 544 year: 2022 ident: bib115 article-title: Mechanisms used by cancer cells to tolerate drug-induced replication stress publication-title: Cancer Lett. – volume: 6 start-page: 584 year: 2016 end-page: 593 ident: bib117 article-title: Role of Telomeres and Telomerase in Aging and Cancer publication-title: Cancer Discov. – volume: 383 start-page: 1218 year: 2020 end-page: 1230 ident: bib101 article-title: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma publication-title: N. Engl. J. Med. – volume: 15 start-page: 80 year: 2014 end-page: 89 ident: bib62 article-title: Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities publication-title: Curr. Drug Targets – volume: 12 start-page: 3189 year: 2020 ident: bib5 article-title: IL-2 and anti-TGF-β promote NK cell reconstitution and anti-tumor effects after syngeneic hematopoietic stem cell transplantation publication-title: Cancers (Basel) – volume: 26 start-page: 690 year: 2019 end-page: 702 ident: bib94 article-title: Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications publication-title: Cell Death Differ. – volume: 8 start-page: 239 year: 2023 ident: bib76 article-title: Inflammation and aging: signaling pathways and intervention therapies publication-title: Signal Transduct. Target Ther. – volume: 42 year: 2022 ident: bib95 article-title: Upregulation of PD-L1 in senescence and aging publication-title: Mol. Cell Biol. – volume: 10 start-page: 770 year: 2022 end-page: 784 ident: bib135 article-title: Circadian regulator CLOCK drives immunosuppression in glioblastoma publication-title: Cancer Immunol. Res – volume: 21 start-page: 400 year: 2023 ident: bib42 article-title: TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer publication-title: J. Transl. Med – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: bib53 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 9 start-page: 485 year: 2021 ident: bib69 article-title: Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype publication-title: Front Cell Dev. Biol. – volume: 10 start-page: 371 year: 2020 end-page: 381 ident: bib18 article-title: Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment publication-title: Cancer Discov. – volume: 128 start-page: 1238 year: 2018 end-page: 1246 ident: bib59 article-title: Mechanisms and functions of cellular senescence publication-title: J. Clin. Invest – volume: 13 start-page: 1281 year: 2024 ident: bib80 article-title: Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence? – volume: 14 start-page: 1566 year: 2023 ident: bib40 article-title: Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade publication-title: Nat. Commun. – volume: 68 start-page: 870 year: 2008 end-page: 879 ident: bib90 article-title: Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion publication-title: Cancer Res – volume: 13 start-page: 4795 year: 2022 ident: bib147 article-title: Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands publication-title: Nat. Commun. – volume: 65 start-page: 7866 year: 2005 end-page: 7873 ident: bib38 article-title: In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor publication-title: Cancer Res – volume: 18 start-page: 175 year: 2019 end-page: 196 ident: bib107 article-title: Delivery technologies for cancer immunotherapy publication-title: Nat. Rev. Drug Discov. – year: 2023 ident: bib50 article-title: Cellular senescence and the host immune system in aging and age-related disorders publication-title: Biomed. J. – volume: 10 start-page: 2387 year: 2019 ident: bib100 article-title: Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition publication-title: Nat. Commun. – volume: 7 year: 2016 ident: bib109 article-title: Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis publication-title: Nat. Commun. – volume: 21 start-page: 120 year: 2022 ident: bib23 article-title: AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p publication-title: Mol. Cancer – volume: 186 start-page: 1432 year: 2023 end-page: 1447 ident: bib60 article-title: T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants publication-title: Cell – volume: 54 year: 2022 ident: bib144 article-title: Long noncoding RNA MAGI2-AS3 regulates the H(2)O(2) level and cell senescence via HSPA8 publication-title: Redox Biol. – volume: 118 year: 2021 ident: bib15 article-title: Molecular mechanism of the repressive phase of the mammalian circadian clock publication-title: Proc. Natl. Acad. Sci. USA – volume: 87 start-page: 1071 year: 2007 end-page: 1076 ident: bib33 article-title: Role of telomeres and telomerase in genomic instability, senescence and cancer publication-title: Lab Invest – volume: 28 start-page: 2100 year: 2009 end-page: 2113 ident: bib72 article-title: Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis publication-title: Embo J. – volume: 1 start-page: 131 year: 2005 end-page: 140 ident: bib26 article-title: Autophagy and aging: the importance of maintaining "clean" cells publication-title: Autophagy – volume: 22 year: 2021 ident: bib97 article-title: Immune regulatory processes of the tumor microenvironment under malignant conditions publication-title: Int J. Mol. Sci. – volume: 36 start-page: 533 year: 2022 end-page: 549 ident: bib140 article-title: Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance publication-title: Genes Dev. – volume: 34 start-page: 1565 year: 2020 end-page: 1576 ident: bib10 article-title: Senescence and the SASP: many therapeutic avenues publication-title: Genes Dev. – volume: 3 start-page: 1290 year: 2021 end-page: 1301 ident: bib132 article-title: The metabolic roots of senescence: mechanisms and opportunities for intervention publication-title: Nat. Metab. – volume: 153 start-page: 1194 year: 2013 end-page: 1217 ident: bib83 article-title: The hallmarks of aging publication-title: Cell – volume: 15 start-page: 2634 year: 2021 end-page: 2671 ident: bib96 article-title: Cellular senescence in cancer: from mechanisms to detection publication-title: Mol. Oncol. – volume: 117 start-page: 1644 year: 2017 end-page: 1655 ident: bib127 article-title: Interleukin-10-regulated tumour tolerance in non-small cell lung cancer publication-title: Br. J. Cancer – volume: 30 start-page: 533 year: 2016 end-page: 547 ident: bib43 article-title: Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression publication-title: Cancer Cell – volume: 186 start-page: 243 year: 2023 end-page: 278 ident: bib84 article-title: Hallmarks of aging: an expanding universe publication-title: Cell – volume: 33 start-page: 110 year: 2021 end-page: 127 ident: bib86 article-title: NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion publication-title: Cell Metab. – volume: 13 year: 2021 ident: bib78 article-title: Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy publication-title: Sci. Transl. Med – volume: 31 start-page: 798 year: 2020 end-page: 806 ident: bib99 article-title: Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial. Annals of oncology: official journal of the European Society for publication-title: Med. Oncol. – volume: 22 start-page: 435 year: 2022 ident: bib75 article-title: Circadian clock gene Clock-Bmal1 regulates cellular senescence in Chronic obstructive pulmonary disease publication-title: BMC Pulm. Med – volume: 14 start-page: 1423 year: 2018 end-page: 1431 ident: bib124 article-title: Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells publication-title: Hum. Vaccin Immunother. – volume: 6 issue: 42 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib3 article-title: Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation publication-title: Sci. Adv. doi: 10.1126/sciadv.aaz4530 – volume: 186 start-page: 1432 issue: 7 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib60 article-title: T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants publication-title: Cell doi: 10.1016/j.cell.2023.03.007 – volume: 15 start-page: 978 issue: 8 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib2 article-title: A complex secretory program orchestrated by the inflammasome controls paracrine senescence publication-title: Nat. Cell Biol. doi: 10.1038/ncb2784 – volume: 66 start-page: 1286 issue: 7 year: 2017 ident: 10.1016/j.critrevonc.2025.104628_bib11 article-title: Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma publication-title: Gut doi: 10.1136/gutjnl-2016-312268 – volume: 75 start-page: 685 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib14 article-title: Aging, cellular senescence, and cancer publication-title: Annu Rev. Physiol. doi: 10.1146/annurev-physiol-030212-183653 – volume: 117 start-page: 1644 issue: 11 year: 2017 ident: 10.1016/j.critrevonc.2025.104628_bib127 article-title: Interleukin-10-regulated tumour tolerance in non-small cell lung cancer publication-title: Br. J. Cancer doi: 10.1038/bjc.2017.336 – volume: 12 start-page: 5938 issue: 19 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib19 article-title: INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer publication-title: J. Cancer doi: 10.7150/jca.61556 – volume: 12 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib35 article-title: Cancer immune evasion through loss of MHC class I antigen presentation publication-title: Front Immunol. doi: 10.3389/fimmu.2021.636568 – volume: 21 start-page: 400 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib42 article-title: TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer publication-title: J. Transl. Med doi: 10.1186/s12967-023-04257-6 – volume: 5 start-page: 14 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib92 article-title: Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging publication-title: JCI Insight – volume: 120 issue: 2 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib103 article-title: Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2214829120 – volume: 18 start-page: 175 issue: 3 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib107 article-title: Delivery technologies for cancer immunotherapy publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-018-0006-z – volume: 611 start-page: 358 issue: 7935 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib130 article-title: Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes publication-title: Nature doi: 10.1038/s41586-022-05388-4 – volume: 10 start-page: 176 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib122 article-title: Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1 publication-title: Cell Mol. Immunol. doi: 10.1038/cmi.2012.67 – volume: 23 start-page: 75 issue: 2 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib146 article-title: DNA damage and repair in age-related inflammation publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-022-00751-y – volume: 9 start-page: 557 issue: 5 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib32 article-title: Immunosurveillance of cancer and viral infections with regard to alterations of human NK cells originating from lifestyle and aging publication-title: Biomedicines doi: 10.3390/biomedicines9050557 – volume: 33 start-page: 110 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib86 article-title: NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.10.021 – volume: 26 start-page: 690 issue: 4 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib94 article-title: Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0292-y – volume: 36 start-page: 533 issue: 9-10 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib140 article-title: Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance publication-title: Genes Dev. doi: 10.1101/gad.349585.122 – volume: 14 start-page: 333 issue: 2 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib65 article-title: Senescence connects autophagy deficiency to inflammation and tumor progression in the liver publication-title: Cell Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2022.04.003 – volume: 74 start-page: 1971 issue: 4 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib118 article-title: Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy publication-title: Hepatology doi: 10.1002/hep.31872 – volume: 29 start-page: 639 issue: 7 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib8 article-title: Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/s41594-022-00790-y – volume: 12 start-page: 3189 issue: 11 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib5 article-title: IL-2 and anti-TGF-β promote NK cell reconstitution and anti-tumor effects after syngeneic hematopoietic stem cell transplantation publication-title: Cancers (Basel) doi: 10.3390/cancers12113189 – volume: 22 issue: 24 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib97 article-title: Immune regulatory processes of the tumor microenvironment under malignant conditions publication-title: Int J. Mol. Sci. doi: 10.3390/ijms222413311 – volume: 23 issue: 3 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib131 article-title: Comprehensive assessment of cellular senescence in the tumor microenvironment publication-title: Brief. Bioinform doi: 10.1093/bib/bbac118 – volume: 30 start-page: 533 issue: 4 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib43 article-title: Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.09.003 – volume: 40 year: 2018 ident: 10.1016/j.critrevonc.2025.104628_bib102 article-title: Senescent cell clearance by the immune system: emerging therapeutic opportunities publication-title: Semin Immunol. doi: 10.1016/j.smim.2019.04.003 – volume: 21 start-page: 120 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib23 article-title: AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p publication-title: Mol. Cancer doi: 10.1186/s12943-022-01581-1 – volume: 81 start-page: 87 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib20 article-title: METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2021-221091 – volume: 17 start-page: 1205 issue: 9 year: 2015 ident: 10.1016/j.critrevonc.2025.104628_bib58 article-title: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype publication-title: Nat. Cell Biol. doi: 10.1038/ncb3225 – volume: 132 issue: 8 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib106 article-title: Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity publication-title: J. Clin. Invest doi: 10.1172/JCI153167 – volume: 24 start-page: 177 issue: 2 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib89 article-title: The hallmarks of cancer… in pituitary tumors? publication-title: Rev. Endocr. Metab. Disord. doi: 10.1007/s11154-022-09777-y – volume: 40 start-page: 178 issue: 2 year: 2014 ident: 10.1016/j.critrevonc.2025.104628_bib27 article-title: Circadian clock proteins and immunity publication-title: Immunity doi: 10.1016/j.immuni.2014.02.002 – volume: 2 start-page: 676 issue: 11 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib104 article-title: SASP: tumor suppressor or promoter? yes! publication-title: Trends Cancer doi: 10.1016/j.trecan.2016.10.001 – volume: 73 start-page: 2587 issue: 8 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib125 article-title: MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-2807 – volume: 9 start-page: 1 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib4 article-title: Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging publication-title: Cells doi: 10.3390/cells9010195 – volume: 128 start-page: 1238 issue: 4 year: 2018 ident: 10.1016/j.critrevonc.2025.104628_bib59 article-title: Mechanisms and functions of cellular senescence publication-title: J. Clin. Invest doi: 10.1172/JCI95148 – volume: 6 start-page: 584 issue: 6 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib117 article-title: Role of Telomeres and Telomerase in Aging and Cancer publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-16-0062 – volume: 295 start-page: 11144 issue: 32 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib1 article-title: Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA120.012962 – volume: 33 start-page: 9 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib24 article-title: The heterogeneity of cellular senescence: insights at the single-cell level publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2022.04.011 – volume: 32 start-page: 4235 issue: 12 year: 2024 ident: 10.1016/j.critrevonc.2025.104628_bib71 article-title: PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders publication-title: Mol. Ther.: J. Am. Soc. Gene Ther. doi: 10.1016/j.ymthe.2024.09.026 – volume: 7 start-page: 41 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib45 article-title: Molecular regulations of circadian rhythm and implications for physiology and diseases publication-title: Signal Transduct. Target Ther. doi: 10.1038/s41392-022-00899-y – volume: 12 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib88 article-title: Cellular senescence enhances adaptive anticancer immunosurveillance publication-title: Oncoimmunology doi: 10.1080/2162402X.2022.2154115 – volume: 17 start-page: 54 issue: 1 year: 2024 ident: 10.1016/j.critrevonc.2025.104628_bib21 article-title: Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-024-01581-2 – volume: 150 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib123 article-title: SIRT1 suppresses cellular senescence and inflammatory cytokine release in human dermal fibroblasts by promoting the deacetylation of NF-κB and activating autophagy publication-title: Exp. Gerontol. doi: 10.1016/j.exger.2021.111394 – volume: 181 start-page: 424 issue: 2 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib110 article-title: Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer publication-title: Cell doi: 10.1016/j.cell.2020.03.008 – volume: 12 start-page: 7041 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib34 article-title: Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance publication-title: Nat. Commun. doi: 10.1038/s41467-021-27349-7 – volume: 6 start-page: 6967 year: 2015 ident: 10.1016/j.critrevonc.2025.104628_bib91 article-title: The lncRNA MIR31HG regulates p16(INK4A) expression to modulate senescence publication-title: Nat. Commun. doi: 10.1038/ncomms7967 – volume: 9 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib136 article-title: The Paradoxical role of cellular senescence in cancer publication-title: Front Cell Dev. Biol. doi: 10.3389/fcell.2021.759761 – volume: 22 start-page: 75 issue: 2 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib36 article-title: Cellular senescence in ageing: from mechanisms to therapeutic opportunities publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-020-00314-w – volume: 132 issue: 15 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib143 article-title: Cellular senescence: a key therapeutic target in aging and diseases publication-title: J. Clin. Invest doi: 10.1172/JCI158450 – volume: 383 start-page: 1328 issue: 14 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib57 article-title: Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1917346 – volume: 43 start-page: 17 year: 2018 ident: 10.1016/j.critrevonc.2025.104628_bib12 article-title: Cellular senescence: Immunosurveillance and future immunotherapy publication-title: Ageing Res Rev. doi: 10.1016/j.arr.2018.02.001 – volume: 14 start-page: 1302 issue: 7 year: 2024 ident: 10.1016/j.critrevonc.2025.104628_bib138 article-title: Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-23-0426 – volume: 14 start-page: 441 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib112 article-title: Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma publication-title: Nat. Commun. doi: 10.1038/s41467-023-36124-9 – volume: 13 issue: 9 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib16 article-title: LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A publication-title: Clin. Transl. Med. doi: 10.1002/ctm2.1418 – volume: 12 start-page: 31 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib52 article-title: Hallmarks of cancer: new dimensions publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-21-1059 – volume: 18 issue: 6 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib134 article-title: Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression publication-title: Aging Cell doi: 10.1111/acel.13027 – volume: 20 start-page: 105 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib81 article-title: N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer publication-title: Mol. Cancer doi: 10.1186/s12943-021-01398-4 – volume: 26 start-page: 516 issue: 3 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib64 article-title: The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21 publication-title: Cell Death Differ. doi: 10.1038/s41418-018-0141-4 – volume: 13 issue: 12 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib114 article-title: Combination of antiretroviral drugs Zidovudine and Efavirenz impairs tumor growths in a mouse model of cancer publication-title: Viruses doi: 10.3390/v13122396 – volume: 176 start-page: 11 issue: 1-2 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib74 article-title: Biological functions of autophagy genes: a disease perspective publication-title: Cell doi: 10.1016/j.cell.2018.09.048 – volume: 115 start-page: 230 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib61 article-title: Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling publication-title: Cardiovasc Res doi: 10.1093/cvr/cvy206 – volume: 22 issue: 5 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib93 article-title: Immunomodulation by Inflammation during liver and gastrointestinal tumorigenesis and aging publication-title: Int J. Mol. Sci. doi: 10.3390/ijms22052238 – volume: 12 start-page: 252 issue: 4 year: 2012 ident: 10.1016/j.critrevonc.2025.104628_bib98 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3239 – volume: 13 start-page: 4795 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib147 article-title: Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands publication-title: Nat. Commun. doi: 10.1038/s41467-022-32311-2 – volume: 13 start-page: 432 issue: 2 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib17 article-title: Senescence rewires microenvironment sensing to facilitate antitumor immunity publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-22-0528 – volume: 10 start-page: 2387 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib100 article-title: Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition publication-title: Nat. Commun. doi: 10.1038/s41467-019-10335-5 – volume: 8 start-page: 239 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib76 article-title: Inflammation and aging: signaling pathways and intervention therapies publication-title: Signal Transduct. Target Ther. doi: 10.1038/s41392-023-01502-8 – volume: 42 issue: 10 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib95 article-title: Upregulation of PD-L1 in senescence and aging publication-title: Mol. Cell Biol. doi: 10.1128/mcb.00171-22 – volume: 17 start-page: 1049 issue: 8 year: 2015 ident: 10.1016/j.critrevonc.2025.104628_bib70 article-title: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation publication-title: Nat. Cell Biol. doi: 10.1038/ncb3195 – volume: 10 issue: 10 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib79 article-title: Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2022-005020 – volume: 9 start-page: 485 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib69 article-title: Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype publication-title: Front Cell Dev. Biol. doi: 10.3389/fcell.2021.645593 – volume: 22 start-page: 435 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib75 article-title: Circadian clock gene Clock-Bmal1 regulates cellular senescence in Chronic obstructive pulmonary disease publication-title: BMC Pulm. Med doi: 10.1186/s12890-022-02237-y – volume: 12 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib66 article-title: p16(INK4a) regulates cellular senescence in PD-1-expressing human T cells publication-title: Front Immunol. doi: 10.3389/fimmu.2021.698565 – volume: 24 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib54 article-title: Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype publication-title: iScience doi: 10.1016/j.isci.2020.102016 – volume: 35 start-page: 1963 issue: 9 year: 2015 ident: 10.1016/j.critrevonc.2025.104628_bib49 article-title: Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.115.305896 – volume: 137 start-page: 2785 issue: 20 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib105 article-title: Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas publication-title: Blood doi: 10.1182/blood.2020005244 – volume: 50 start-page: 924 issue: 4 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib9 article-title: Transforming growth factor-β signaling in immunity and cancer publication-title: Immunity doi: 10.1016/j.immuni.2019.03.024 – volume: 127 start-page: 437 issue: 2 year: 2017 ident: 10.1016/j.critrevonc.2025.104628_bib63 article-title: The aging clock: circadian rhythms and later life publication-title: J. Clin. Invest doi: 10.1172/JCI90328 – volume: 89 start-page: 31 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib128 article-title: Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of CDK4/6-Cyclin D-Rb pathway publication-title: Cancer Chemother. Pharm. doi: 10.1007/s00280-021-04363-6 – volume: 31 start-page: 798 issue: 6 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib99 article-title: Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial. Annals of oncology: official journal of the European Society for publication-title: Med. Oncol. – volume: 68 start-page: 870 issue: 3 year: 2008 ident: 10.1016/j.critrevonc.2025.104628_bib90 article-title: Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-2282 – volume: 186 start-page: 243 issue: 2 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib84 article-title: Hallmarks of aging: an expanding universe publication-title: Cell doi: 10.1016/j.cell.2022.11.001 – year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib50 article-title: Cellular senescence and the host immune system in aging and age-related disorders publication-title: Biomed. J. doi: 10.1016/j.bj.2023.02.001 – volume: 383 start-page: 1218 issue: 13 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib101 article-title: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002788 – volume: 13 start-page: 4561 issue: 18 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib28 article-title: Cellular plasticity: a route to senescence exit and tumorigenesis publication-title: Cancers (Basel) doi: 10.3390/cancers13184561 – volume: 9 issue: 1 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib30 article-title: Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy publication-title: Oncoimmunology doi: 10.1080/2162402X.2020.1715767 – volume: 7 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib109 article-title: Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis publication-title: Nat. Commun. doi: 10.1038/ncomms11762 – volume: 27 start-page: 1844 issue: 6 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib73 article-title: A novel long noncoding RNA Linc-ASEN represses cellular senescence through multileveled reduction of p21 expression publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0467-6 – volume: 99 start-page: 1047 issue: 2 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib13 article-title: Cellular senescence: aging, cancer, and injury publication-title: Physiol. Rev. doi: 10.1152/physrev.00020.2018 – volume: 118 issue: 2 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib15 article-title: Molecular mechanism of the repressive phase of the mammalian circadian clock publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2021174118 – volume: 12 start-page: 401 issue: 1 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib116 article-title: The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair publication-title: Nat. Commun. doi: 10.1038/s41467-020-20513-5 – volume: 24 start-page: 560 issue: 8 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib31 article-title: Autophagy and autophagy-related pathways in cancer publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/s41580-023-00585-z – volume: 132 issue: 3 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib108 article-title: JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice publication-title: J. Clin. Invest doi: 10.1172/JCI145071 – volume: 18 start-page: 480 issue: 5 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib129 article-title: Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing publication-title: Nat. Cell Biol. doi: 10.1038/ncb3342 – volume: 5 issue: 5 year: 2024 ident: 10.1016/j.critrevonc.2025.104628_bib67 article-title: Cellular senescence in cancer: molecular mechanisms and therapeutic targets – volume: 13 start-page: 1281 issue: 15 year: 2024 ident: 10.1016/j.critrevonc.2025.104628_bib80 article-title: Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence? – volume: 1 start-page: 131 issue: 3 year: 2005 ident: 10.1016/j.critrevonc.2025.104628_bib26 article-title: Autophagy and aging: the importance of maintaining "clean" cells publication-title: Autophagy doi: 10.4161/auto.1.3.2017 – volume: 105 start-page: 861 issue: 4 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib39 article-title: BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition publication-title: Int J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2019.08.009 – volume: 186 start-page: 528 issue: 3 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib141 article-title: Cyclin E-induced replicative stress drives p53-dependent whole-genome duplication publication-title: Cell doi: 10.1016/j.cell.2022.12.036 – volume: 10 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib77 article-title: Hepatocellular senescence: immunosurveillance and future senescence-induced therapy in hepatocellular carcinoma publication-title: Front Oncol. doi: 10.3389/fonc.2020.589908 – volume: 86 start-page: 827 issue: Pt 3 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib22 article-title: Senescence and the tumor-immune landscape: Implications for cancer immunotherapy publication-title: Semin Cancer Biol. doi: 10.1016/j.semcancer.2022.02.005 – volume: 28 start-page: 2100 issue: 14 year: 2009 ident: 10.1016/j.critrevonc.2025.104628_bib72 article-title: Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis publication-title: Embo J. doi: 10.1038/emboj.2009.164 – volume: 13 issue: 587 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib78 article-title: Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy publication-title: Sci. Transl. Med doi: 10.1126/scitranslmed.aaz6314 – volume: 8 start-page: 328 issue: 2 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib111 article-title: NKG2D ligands mediate immunosurveillance of senescent cells publication-title: Aging (Albany NY) doi: 10.18632/aging.100897 – volume: 29 issue: 3 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib41 article-title: Hallmarks of senescence and aging publication-title: Biochem Med (Zagreb) doi: 10.11613/BM.2019.030501 – volume: 11 start-page: 4929 issue: 10 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib133 article-title: Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2 publication-title: Theranostics doi: 10.7150/thno.55672 – volume: 14 start-page: 1566 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib40 article-title: Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade publication-title: Nat. Commun. doi: 10.1038/s41467-023-36878-2 – volume: 64 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib126 article-title: Single-cell analyses of aging, inflammation and senescence publication-title: Ageing Res Rev. doi: 10.1016/j.arr.2020.101156 – volume: 25 start-page: 585 issue: 3 year: 1961 ident: 10.1016/j.critrevonc.2025.104628_bib55 article-title: The serial cultivation of human diploid cell strains publication-title: Exp. Cell Res. doi: 10.1016/0014-4827(61)90192-6 – volume: 19 start-page: 439 issue: 8 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib44 article-title: Unmasking senescence: context-dependent effects of SASP in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0156-2 – volume: 275 start-page: e626 issue: 4 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib142 article-title: Poor clinical outcomes and immunoevasive contexture in intratumoral IL-10-producing macrophages enriched gastric cancer patients publication-title: Ann. Surg. doi: 10.1097/SLA.0000000000004037 – volume: 3 start-page: 1290 issue: 10 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib132 article-title: The metabolic roots of senescence: mechanisms and opportunities for intervention publication-title: Nat. Metab. doi: 10.1038/s42255-021-00483-8 – volume: 3 start-page: 273 issue: 4 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib119 article-title: Therapy-induced senescent tumor cells in cancer relapse publication-title: J. Natl. Cancer Cent. doi: 10.1016/j.jncc.2023.09.001 – volume: 566 start-page: 73 issue: 7742 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib29 article-title: L1 drives IFN in senescent cells and promotes age-associated inflammation publication-title: Nature doi: 10.1038/s41586-018-0784-9 – volume: 41 start-page: 2983 issue: 31 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib121 article-title: Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehz919 – volume: 10 start-page: 770 issue: 6 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib135 article-title: Circadian regulator CLOCK drives immunosuppression in glioblastoma publication-title: Cancer Immunol. Res doi: 10.1158/2326-6066.CIR-21-0559 – volume: 9 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib145 article-title: Comprehensive Pan-cancer analysis of senescence with cancer prognosis and immunotherapy publication-title: Front Mol. Biosci. doi: 10.3389/fmolb.2022.919274 – volume: 21 issue: 6 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib148 article-title: TLR3 mediates senescence and immunosurveillance of hepatic stellate cells publication-title: Hepat. Mon. doi: 10.5812/hepatmon.114381 – volume: 15 start-page: 80 issue: 1 year: 2014 ident: 10.1016/j.critrevonc.2025.104628_bib62 article-title: Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities publication-title: Curr. Drug Targets doi: 10.2174/1389450114666140106101412 – volume: 19 start-page: 1121 issue: 10 year: 2004 ident: 10.1016/j.critrevonc.2025.104628_bib47 article-title: Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2004.03467.x – volume: 153 start-page: 1194 issue: 6 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib83 article-title: The hallmarks of aging publication-title: Cell doi: 10.1016/j.cell.2013.05.039 – volume: 43 start-page: 67 year: 2009 ident: 10.1016/j.critrevonc.2025.104628_bib56 article-title: Regulation mechanisms and signaling pathways of autophagy publication-title: Annu Rev. Genet doi: 10.1146/annurev-genet-102808-114910 – volume: 19 start-page: 619 issue: 10 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib113 article-title: Senescence and cancer - role and therapeutic opportunities publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-022-00668-4 – volume: 87 start-page: 1071 issue: 11 year: 2007 ident: 10.1016/j.critrevonc.2025.104628_bib33 article-title: Role of telomeres and telomerase in genomic instability, senescence and cancer publication-title: Lab Invest doi: 10.1038/labinvest.3700673 – volume: 20 start-page: 89 issue: 2 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib46 article-title: How the ageing microenvironment influences tumour progression publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0222-9 – volume: 25 start-page: 214 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2025.104628_bib25 article-title: T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2012.12.003 – volume: 35 start-page: 12 issue: 1 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib85 article-title: Meta-hallmarks of aging and cancer publication-title: Cell Metab. doi: 10.1016/j.cmet.2022.11.001 – volume: 144 start-page: 646 issue: 5 year: 2011 ident: 10.1016/j.critrevonc.2025.104628_bib53 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 220 start-page: 82 year: 2007 ident: 10.1016/j.critrevonc.2025.104628_bib120 article-title: From cancer immunosurveillance to cancer immunotherapy publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2007.00566.x – volume: 34 issue: 8 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib137 article-title: Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.108779 – volume: 65 start-page: 7866 issue: 17 year: 2005 ident: 10.1016/j.critrevonc.2025.104628_bib38 article-title: In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1215 – volume: 8 issue: 2 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib82 article-title: Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2020-000978 – volume: 51 start-page: 27 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib51 article-title: Inflammation and cancer: triggers, mechanisms, and consequences publication-title: Immunity doi: 10.1016/j.immuni.2019.06.025 – volume: 21 start-page: 28 issue: 1 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib139 article-title: Combination strategies with PD-1/PD-L1 blockade: current advances and future directions publication-title: Mol. Cancer doi: 10.1186/s12943-021-01489-2 – volume: 105 start-page: 1275 issue: 6 year: 2019 ident: 10.1016/j.critrevonc.2025.104628_bib6 article-title: Senescent cells: Living or dying is a matter of NK cells publication-title: J. Leukoc. Biol. doi: 10.1002/JLB.MR0718-299R – volume: 26 start-page: 215 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib37 article-title: Non-cell-autonomous regulation of cellular senescence in cancer publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2015.10.005 – volume: 13 start-page: 410 issue: 2 year: 2023 ident: 10.1016/j.critrevonc.2025.104628_bib87 article-title: Cellular senescence is immunogenic and promotes antitumor immunity publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-22-0523 – volume: 9 issue: 3 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib48 article-title: Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2020-001536 – volume: 15 start-page: 2634 issue: 10 year: 2021 ident: 10.1016/j.critrevonc.2025.104628_bib96 article-title: Cellular senescence in cancer: from mechanisms to detection publication-title: Mol. Oncol. doi: 10.1002/1878-0261.12807 – volume: 9 start-page: 790 year: 2018 ident: 10.1016/j.critrevonc.2025.104628_bib7 article-title: Hallmarks of aging: an autophagic perspective publication-title: Front Endocrinol. (Lausanne) doi: 10.3389/fendo.2018.00790 – volume: 544 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib115 article-title: Mechanisms used by cancer cells to tolerate drug-induced replication stress publication-title: Cancer Lett. doi: 10.1016/j.canlet.2022.215804 – volume: 14 start-page: 1423 issue: 6 year: 2018 ident: 10.1016/j.critrevonc.2025.104628_bib124 article-title: Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells publication-title: Hum. Vaccin Immunother. doi: 10.1080/21645515.2018.1431598 – volume: 12 start-page: 898 issue: 5 year: 2016 ident: 10.1016/j.critrevonc.2025.104628_bib68 article-title: How autophagy both activates and inhibits cellular senescence publication-title: Autophagy doi: 10.1080/15548627.2015.1121361 – volume: 54 year: 2022 ident: 10.1016/j.critrevonc.2025.104628_bib144 article-title: Long noncoding RNA MAGI2-AS3 regulates the H(2)O(2) level and cell senescence via HSPA8 publication-title: Redox Biol. doi: 10.1016/j.redox.2022.102383 – volume: 34 start-page: 1565 issue: 23-24 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib10 article-title: Senescence and the SASP: many therapeutic avenues publication-title: Genes Dev. doi: 10.1101/gad.343129.120 – volume: 10 start-page: 371 issue: 3 year: 2020 ident: 10.1016/j.critrevonc.2025.104628_bib18 article-title: Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-19-0400 |
| SSID | ssj0004467 |
| Score | 2.455513 |
| SecondaryResourceType | review_article |
| Snippet | Cellular senescence, a hallmark of aging, has emerged as a captivating area of research in tumor immunology with profound implications for cancer prevention... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 104628 |
| SubjectTerms | Animals Autophagy Autophagy - immunology Cellular senescence Cellular Senescence - immunology Humans Immunotherapy Immunotherapy - methods Inflammation Neoplasms - immunology Neoplasms - pathology Neoplasms - therapy Tumor Escape - immunology Tumor immune escape Tumor Microenvironment - immunology |
| Title | Cellular senescence in tumor immune escape: Mechanisms, implications, and therapeutic potential |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1040842825000162 https://dx.doi.org/10.1016/j.critrevonc.2025.104628 https://www.ncbi.nlm.nih.gov/pubmed/39864532 https://www.proquest.com/docview/3160068837 |
| Volume | 208 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA5DQXwR784bEXy0rm3SNdUnGY6pzBcVfAtpcwaV2Y6t89Hf7jm9OAUFwcemTducJF_OId93wtgprolJLCLrWBMKR3ZV7ETKt44ZeYlrVaIgIe3w8L47eJK3z8Fzi_UaLQzRKmvsrzC9ROu6pFNbszNJ084DBhKukqS9LB0XwmEpQxrl5-8LmgeGO2GVkcB16OmazVNxvHBiFlN4yzNKZugH5YYnncv-8xL1mwtaLkX9dbZW-5D8qvrNDdaCbJOtDOtd8i2mezAeE72UzwjJEmoUTzNezF_zKU9JEQIcy80ELvgQSPubzl5nZ3hrsZt9xk1m-Rd5Fp_kBVGLzHibPfavH3sDpz5IwUkQPwonsFbFyo0xtJHCAnoFUgFaQJnYjYMQcFJDV3qyTJ7n-66IJACohMpDUGKHLWV5BnuM-8nI8y06BVYEUhrKHoaQEPgRvmlkolGbeY3p9KRKl6EbHtmLXphbk7l1Ze42ixob60YOigCmEdP_UPfys-63YfPH2idNl2qcVbRVYjLI5zMtvC6JZzB6b7Pdqq8_2yMoo30g_P1_ffuArdJVRQI6ZEvFdA5H6N8U8XE5gI_Z8tXN3eD-AxvF-ws |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED6hIo29oDHGKBvMSHskahI7rbM9oQpUBu0LncSb5cRXKagkVZvy93OXH3RITELi1c4l8dn-fKe77wzwk87ENJGx85wdSE_1deLFOnSenQWp73SqMWXu8HjSH_1Vf-6iuy0YtlwYTqtssL_G9Aqtm5Zeo83eIst6t-RI-Fox97IyXAiHt7k6VdSB7fOr69FkQ49U1UWy_LzHAk1CT53mRXuzXOJjkXM9wzCqYp58Nfvrp9T_rNDqNLr8BLuNGSnO6z_dgy3MP8OHcRMo3wczxPmcM0zFisEs5XGJLBfl-qFYioxJISio3S7wlxgj03-z1cPqjLo2Ae0zYXMn_mFoiUVRcnaRnX-B6eXFdDjymrsUvJQgpPQi53Si_YS8GyUdkmGgNJIGtE38JBog7Wvsq0BV9fPC0JexQkSdcvsAtTyATl7keAgiTGdB6MgucDJSynIBMUKFKIzpTTMbz7oQtKozi7pihmlTye7NRt2G1W1qdXchbnVsWkYoYZghWH-D7O9n2Rcr543Sp-2UGtpYHC2xORbrlZFBn_kz5MB34Ws918_jkVzUPpLh0bu-_QN2RtPxjbm5mlx_g4_cU-cEfYdOuVzjMZk7ZXLSLOcnsqz9vA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cellular+senescence+in+tumor+immune+escape%3A+Mechanisms%2C+implications%2C+and+therapeutic+potential&rft.jtitle=Critical+reviews+in+oncology%2Fhematology&rft.au=You%2C+Li&rft.au=Wu%2C+Qinghua&rft.date=2025-04-01&rft.pub=Elsevier+B.V&rft.issn=1040-8428&rft.volume=208&rft_id=info:doi/10.1016%2Fj.critrevonc.2025.104628&rft.externalDocID=S1040842825000162 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-8428&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-8428&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-8428&client=summon |